Dr. Hardik Satish Chhatrala, MD

Dr. Chhatrala practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Chhatrala's NPI, 1447661723, was assigned on May 8, 2014. Dr. Chhatrala graduated from Pramukhswami Medical College in 2011. Dr. Chhatrala holds Florida license ME147990.

Dr. Chhatrala's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

Dr. Chhatrala's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Chhatrala is also affiliated with Ascension St. Vincent's Riverside. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Chhatrala to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chhatrala practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chhatrala's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chhatrala is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Chhatrala's licenses on file in 3 states: Florida, New Jersey and Michigan.

Dmand AI lists chronic anemia, chronic embolism thrombosis, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer, lymphoma and neutropenia among the conditions Dr. Chhatrala treats.

CMS data shows 23,477 Medicare services from Dr. Chhatrala across 24 procedure codes in 2024, for 308 Medicare patients. Medicare paid $114,934 for them.

CMS counts 308 Medicare patients who saw Dr. Chhatrala in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chhatrala's median patient age at 66, with 60% women.

In 2024, Dr. Chhatrala wrote 565 Medicare Part D claims for 119 patients. 71% of them were for generic drugs. CMS names the drug for 350 of them, across 18 drugs with 11 or more claims each, at $746,100 in total drug cost. In 2023, CMS named 215 claims across 11 drugs.

Dr. Chhatrala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chhatrala as offering telehealth.

Dmand AI links 8 papers to Dr. Chhatrala, published from 2016 to 2025. Dr. Chhatrala has published most often in J Investig Med High Impact Case Rep. Dr. Chhatrala's most frequent co-authors are Michael K. Chahin, DO, Nithya Meenakshi Krishnan, MD and Lara Z. Zuberi, MD.

CMS Open Payments shows 78 general payments to Dr. Chhatrala from 39 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $198.

Dr. Chhatrala graduated from Pramukhswami Medical College in 2011.

Dr. Chhatrala is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.